BIOSIMILAR DRUG CONTRIBUTION TARGET

Worker conducts the process of production of drugs in one of the areas of Biosimilar medicine, in Cikarang, West Java, Friday (31/1/2020). Kalbe Farma’s biosimilar drug plant targets the beginning of the drug’s business contribution by 10 percent of the total revenue of prescription drugs, as well as able to meet the needs of biosimilar drugs in Indonesia to 2025. ANTARA PHOTO/Risky Andrianto/hp.